BREASTOX
Live / Allowed — Notice of allowance issued (as of 20 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99715466
- Mark type
- Word mark
- Filed
- 20 Mar 2026
- Published for opposition
- 25 Aug 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs, collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes
- Class 009 — Scientific and electric apparatus: DNA collection kit comprised of DNA collection laboratory swab and swab handle
- Class 010 — Medical apparatus: Specimen collection kits for use in genetic testing comprised primarily of saliva containers for medical purposes sold empty, instructions, shipping labels and transport packaging; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes
- Class 042 — Scientific and technological services: Research and development for the purpose of determining treatment selection for breast cancer
- Class 044 — Medical, beauty and agricultural services: Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with radiation treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with radiation treatments
Owner
- Mira DX, Inc., Los Angeles, CA, US
- Mira DX, Inc., Los Angeles, CA, US
Prosecution history
- 20 Oct 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jul 2026 — ASSIGNED TO EXAMINER
- 29 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 20 Mar 2026 — NEW APPLICATION ENTERED